IHS Chemical Week

BASF acquires 97.7% shares of Pronova BioPharma

11:29 AM MST | January 21, 2013

BASF says that about 97.7% of all shares of Pronova BioPharma (Lysaker, Norway), a pioneer in omega-3 fatty acid research and manufacturing, have been tendered to BASF during the offer period. BASF, in November 2012, reached an agreement with Pronova to make a recommended voluntary public takeover offer to Pronova’s shareholders and offered to pay 12.50 Norwegian kroner in cash for each Pronova share. Earlier this month, BASF increased its offer price to NK13.50/share. The extended offer period for BASF’s voluntary cash offer to Pronova shareholders ended on...

Access is for Chemweek 24/7 PLUS Members ONLY

This information is only available to Chemweek 24/7 PLUS members who have subscribed to Chemweek’s Business Daily. If you are a member, please log in, OR if you have a trial membership, please use your trial membership account information. 


Forgot your user ID or password? Click here to have it sent to you.

contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa